FierceBiotech ١٧ أبريل ٢٠٢٦ A new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipeline
FierceBiotech ١٧ أبريل ٢٠٢٦ Small pools, big ideas: How the rare disease community is reimagining clinical trials
FierceBiotech ١٦ أبريل ٢٠٢٦ RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
FierceBiotech ١٦ أبريل ٢٠٢٦ Rare Disease Research, myTomorrows team up to help patients access trials
FierceBiotech ١٦ أبريل ٢٠٢٦ Aligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal
FierceBiotech ١٦ أبريل ٢٠٢٦ Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech ١٦ أبريل ٢٠٢٦ 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
FierceBiotech ١٦ أبريل ٢٠٢٦ Early-stage funding slumps toward post-pandemic low, piling more pressure on biotech startups
FierceBiotech ١٦ أبريل ٢٠٢٦ FDA advisory committee set to weigh taking action on certain unapproved peptides
FierceBiotech ١٥ أبريل ٢٠٢٦ Was Big Pharma’s ‘unusually aggressive’ M&A spree to blame for March IPO drought?
FierceBiotech ١٥ أبريل ٢٠٢٦ Spain sets up Boston-focused VC fund with goal of raising $200M for biotechs
FierceBiotech ١٥ أبريل ٢٠٢٦ Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
FierceBiotech ١٥ أبريل ٢٠٢٦ Bain-backed Beeline Medicines buzzes out of stealth with $300M and 5 programs from BMS
FierceBiotech ١٥ أبريل ٢٠٢٦ Terremoto takes $108M series C to fuel clinical trials of AKT1 inhibitors